1072P Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome

Authors :: Luigi Nezi
F. Picciotto
Emilia Cocorocchio
M.T. Fierro
T. Manzo
Sara Gandini
G.M. Orsolini
V. Caliendo
Patrizia Gnagnarella
Pietro Quaglino
F. Lotti
Pier Francesco Ferrucci
Giovanni Mazzarol
Elisabetta Pennacchioli
P. Prestianni
Fabio Conforti
Laura Pala
Rebecca Senetta
Simone Ribero
Luca Mazzarella
Source :: Annals of Oncology. 32:S889-S890
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
medicine.medical_treatment
Melanoma
Locally advanced
Ipilimumab
Hematology
Immunotherapy
medicine.disease
Outcome (game theory)
Internal medicine
Medicine
In patient
Nivolumab
business
Adjuvant
medicine.drug

Full Text Access

Tools